黄类药物作为细胞癌中代谢重编程的调节剂 (综述)
Asif Shahzad1, Wenjing Liu1, Yijian Sun1
1Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Kunming Medical University, Kunming, Yunnan 650500, P.R. China.
Oncology reports
|October 18, 2024
概括
黄类药物通过向其代谢重编程,为治疗细胞癌 (RCC) 提供了一种新的方法. 本综述探讨了这些天然化合物如何通过影响RCC瘤中的多种代谢途径来对抗癌症.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 细胞癌 (RCC) 由于遗传突变而表现出显著的代谢重编程.
- 瘤适应营养代谢,以支持癌细胞的生长和存活.
- 目前的疗法往往无法解决这种代谢适应性.
研究的目的:
- 审查RCC中的代谢重编程.
- 探索黄类药物作为向RCC代谢的抗癌剂的潜力.
- 了解RCC中的黄类药物的抗癌机制.
主要方法:
- 在RCC中对代谢重编程进行全面的文献综述.
- 分析黄类物质的特性及其对细胞代谢的影响.
- 审查关于黄类药物和癌症治疗的现有研究.
主要成果:
- RCC代谢的特点是改变的糖解,氧化酸化和脂肪酸合成.
- 黄类药物具有抗氧化和抗炎性质,可以调节多个代谢点.
- 黄类药物在准RCC代谢途径的适应性方面表现有前途.
结论:
- 黄类化合物是开发新型RCC疗法的有前途的天然产品类别.
- 用黄类药物向RCC中的代谢重编程可能提供一种新的治疗策略.
- 对黄类机制的进一步研究可能会导致针对RCC的新型天然抗瘤药物.
相关概念视频
Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


